HSDTSolana CompanyHealthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $2.30 · now $2.30 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, HSDT has typically landed between $1.08 and $3.18 — a range of −53.1% to +38.3% from the issuance price $2.30.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

3,045 overlapping 1 month windows · 2014-06-27 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($2.30) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where HSDT has typically landed a month from the 2026-09-16 close of $2.3 — the range is history, not a prediction.

$1.08worst · -53.1%$3.18best · +38.3%
  • now $2.3 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.97 (-14.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1.59–$2.35
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1.08–$3.18
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 3,045 windows spanning 2014-06-27 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-05-30−95.2%−95.8%+0.0%
2025-05-29−95.1%−95.1%+16.8%
2025-05-28−94.9%−94.9%+14.2%
3 best
2025-08-19+277.6%−8.0%+277.6%
2025-08-15+277.3%−2.5%+277.3%
2025-08-14+270.9%−2.3%+270.9%

3,045 overlapping windows · 2014-06-27 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
42%
−3.3%
n=12
Feb
42%
−7.6%
n=12
Mar
25%
−7.6%
n=12
Apr
25%
−10.0%
n=12
May
50%
−8.7%
n=12
Jun
33%
−11.1%
n=12
Jul
38%
−4.7%
n=13
Aug
38%
−8.5%
n=13
Sep
38%
+8.3%
n=13
Oct
33%
−4.5%
n=12
Nov
33%
−9.2%
n=12
Dec
42%
+7.0%
n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$24$1↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

40 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-21Tjandrasuwita Agustina GaniofficerAward / grant88,81788,817Form 4
2026-07-31Chee Choon WeedirectorAward / grant923,000923,000Form 4
2026-06-02Jiang Cosmo YidirectorWithheld for tax6101,004,430Form 4
2026-06-02Jiang Cosmo YidirectorOption exercise1,005,0401,005,040Form 4
2026-06-02Jiang Cosmo YidirectorOption exercise1,005,0401,005,040Form 4
2026-05-21STRAW EDWARD MdirectorAward / grant6,3608,542Form 4
2026-05-21STRAW EDWARD MdirectorAward / grant18,56418,564Form 4
2026-05-21Walter BlanedirectorAward / grant18,56418,564Form 4
2026-05-21Walter BlanedirectorAward / grant6,3608,542Form 4
2026-05-21Lee Michel Kai TaidirectorAward / grant6,3606,360Form 4
2026-05-21Lee Michel Kai TaidirectorAward / grant18,56418,564Form 4
2026-05-21Mello SergiodirectorAward / grant6,3606,360Form 4
2026-05-21Mello SergiodirectorAward / grant18,56418,564Form 4
2026-05-11Chee Choon WeedirectorOption exercise1,109,1181,109,118Form 4
2026-05-11Summer Wisdom Holdings LtdtenPercentOwnerOther acquisition1,453,2775,377,125Form 4
2026-05-11Fusion Summer LtdtenPercentOwnerOther acquisition1,453,2775,377,125Form 4
2026-05-11Chee Choon WeedirectorOption exercise1,109,1180Form 4
2026-03-31Walter BlanedirectorAward / grant23,52923,529Form 4
2026-03-31Walter BlanedirectorAward / grant2,18095,634Form 4
2026-03-31STRAW EDWARD MdirectorAward / grant2,18092,291Form 4
2026-03-31STRAW EDWARD MdirectorAward / grant23,52923,529Form 4
2026-03-31BUCKMAN PAULdirectorAward / grant2,18092,004Form 4
2026-03-31BUCKMAN PAULdirectorAward / grant23,52923,529Form 4
2026-03-31Perkins Sherrie LdirectorAward / grant2,18092,220Form 4
2026-03-31Perkins Sherrie LdirectorAward / grant23,52923,529Form 4
2025-09-18Jiang Cosmo YidirectorAward / grant1,005,0401,005,040Form 4
2025-09-18Chee Choon WeedirectorAward / grant2,218,2362,218,236Form 4
2025-07-02MATHIESEN JEFFREY SdirectorAward / grant26,20026,200Form 4
2025-07-02Favit-Van Pelt Antonella R.officerAward / grant17,50017,500Form 4
2025-07-02ANDREEFF DANEdirectorAward / grant52,40052,400Form 4
2025-07-02BUCKMAN PAULdirectorAward / grant2,6002,600Form 4
2025-07-02Perkins Sherrie LdirectorAward / grant2,6002,600Form 4
2025-07-02Walter BlanedirectorAward / grant2,6002,600Form 4
2025-01-06STRAW EDWARD MdirectorAward / grant10,73210,732Form 4
2025-01-06Favit-Van Pelt Antonella R.officerAward / grant95,89295,892Form 4
2025-01-06Walter BlanedirectorAward / grant10,73210,732Form 4
2025-01-06ANDREEFF DANEdirectorAward / grant279,715279,715Form 4
2025-01-06BUCKMAN PAULdirectorAward / grant10,73210,732Form 4
2025-01-06MATHIESEN JEFFREY SdirectorAward / grant139,857139,857Form 4
2025-01-06Perkins Sherrie LdirectorAward / grant10,73210,732Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.